1. Chandran M, Chu NV, Edelman SV. Gastrointestinal disturbances in diabetes. Curr Diab Rep 2003;3(1):43-48.

2. Perusicova J. Gastrointestinal complications in diabetes mellitus. Vnitr Lek 2004;50(5):338-343.

3. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001;161(16):1989-1996.

4. Annese V, Bassotti G, Caruso N, et al. Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 1999;29(2):171-177.

5. Kassander P. Asymptomatic gastric retention in diabetes (gastroparesis diabeticorum). Ann Int Med 1958;48:797.

6. Rundles RW. Diabetic neuropathy. General review with report of 125 cases. Medicine 1945;24:111.

7. Malagelada JR, Rees WDR, Mazzotta LJ, Go VLW. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: Effect of metoclopramide and bethanechol. Gastroenterology 1980;78:286.

8. Smith B. Neuropathology of the esophagus in diabetes mellitus. J Neurol Neurosurg Psych 1974;37:1151.

9. Nishida T, Tsuji S, Tsujii M, et al. Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19(3):258-265.

10. Lluch I, Ascaso JF, Mora F, et al. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999;94(4):919-924.

11. Jackson AL, Rashed H, Cardoso S, et al. Assessment of gastric electrical activity and auto-nomic function among diabetic and nondiabetic patients with symptoms of gastroe-sophageal reflux. Dig Dis Sci 2000;45(9):1727-1730.

12. Antwi Ch, Krahulec B, Michalko L, Strbova L, Hlinstakova S, Balazovjech I. Does diabetic autonomic neuropathy influence the clinical manifestations of reflux esophagitis? Bratisl Lek Listy 2003;104(4-5):139-142.

13. Kinekawa F, Kubo F, Matsuda K, et al. Relationship between esophageal dysfunction and neuropathy in diabetic patients. Am J Gastroenterol 2001;96(7):2026-2032.

14. Loo FD, Dodds WJ, Soergel KH, Arndorfer RC, Helm JF, Hogan WJ. Multipeaked esophageal peristaltic pressure waves in patients with diabetic neuropathy. Gastroenterology 1985;88:485.

15. Holloway RH, Tippett MD, Horowitz M, Maddox AF, Moten J, Russo A. Relationship between esophageal motility and transit in patients with type I diabetes mellitus. Am J Gastroenterol 1999;94(11):3150-3157.

16. Lovecek M, Gryga A, Herman J, Svach I, Duda M. Esophageal dysfunction in a female patient with diabetes mellitus and achalasia. Bratisl Lek Listy 2004;105(3):101-103.

17. Clouse RE, Reidel WL, Lustman PJ. Correlation of esophageal motility abnormalities with neuropsychiatry states in diabetics (abstract). Gastroenterology 1985;88:1351.

18. Smith DS, Williams CS, Ferris CD. Diagnosis and treatment of chronic gastroparesis and chronic intestinal pseudo-obstruction. Gastroenterol Clin North Am 2003;32(2):619-658.

19. Smith DS, Ferris CD. Current concepts in diabetic gastroparesis. Drugs 2003;63(13): 1339-1358.

20. Camilleri M. Advances in diabetic gastroparesis. Rev Gastroenterol Disord 2002;2(2): 47-56.

21. Migdalis L, Thomaides T, Chairopoulos C, Kalogeropoulou C, Charalabides J, Mantzara F. Changes of gastric emptying rate and gastrin levels are early indicators of autonomic neuropathy in type II diabetic patients. Clin Auton Res 2001;11(4):259-263.

22. Owyang C, Hasler WL. Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. VI. Pathogenesis and therapeutic approaches to human gastric dysrhythmias. Am J Physiol Gastrointest Liver Physiol 2002;283(1):G8-G15.

23. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M. Gastric emptying in diabetes: clinical significance and treatment. Diabete Med 2002;19(3):177-194.

24. Folwaczny C, Wawarta R, Otto B, Friedrich S, Landgraf R, Riepl RL. Gastric emptying of solid and liquid meals in healthy controls compared with long-term type-1 diabetes mellitus under optimal glucose control. Exp Clin Endocrinol Diabetes 2003;111(4): 223-229.

25. Horowitz M, Jones KL, Harding PE, Wishart JM. Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. Digestion 2002;65(1):41-46.

26. De Block CE, De Leeuw IH, Pelckmans PA, Callens D, Maday E, Van Gaal LF. Delayed gastric emptying and gastric autoimmunity in type 1 diabetes. Diabetes Care 2002; 25(5):912-917.

27. Azami Y. Diabetes mellitus associated with superior mesenteric artery syndrome: report of two cases. Int Med 2001;40(8):736-739.

28. Horowitz M, Su YC, Rayner CK, Jones KL. Gastroparesis: prevalence, clinical significance and treatment. Can J Gastroenterol 2001;15(12):805-813.

29. Tomi S, Plazinska M, Zagorowicz E, Ziolkowski B, Muszynski J. Gastric emptying disorders in diabetes mellitus. Pol Arch Med Wewn 2002;108(3):879-886.

30. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26(5):1553-1579.

31. Lehmann R, Honegger RA, Feinle C, Fried M, Spinas GA, Schwizer W. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug. Exp Clin Endocrinol Diabete 2003;111(5):255-261.

32. Braden B, Enghofer M, Schaub M, Usadel KH, Caspary WF, Lembcke B. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. Aliment Pharmacol Ther 2002;16(7):1341-1346.

33. Zahn A, Langhans CD, Hoffner S, et al. Measurement of gastric emptying by 13C-octanoic acid breath test versus scintigraphy in diabetics. Z Gastroenterol 2003;41(5):383-390.

34. Kockar MC, Kayahan IK, Bavbek N. Diabetic gastroparesis in association with autonomic neuropathy and microvasculopathy. Acta Med Okayama 2002;56(5):237-243.

35. Huszno B, Trofimiuk M, Placzkiewicz E, et al. Co-occurrence of diabetic gastropathy and cardiovascular vegetative neuropathy in patients with diabetes type 1. Folia Med Cracov 2001;42(3):105-111.

36. Jones KL, Russo A, Berry MK, Stevens JE, Wishart JM, Horowitz M. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes melli-tus. Am J Med 2002;113(6):449-455.

37. James AN, Ryan JP, Crowell MD, Parkman HP. Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoniner-gic stimulation. Am J Physiol Gastrointest Liver Physiol 2004;287(3):G612-G619. Epub 2004.

38. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetic gastroparesis. Gastroenterology 90:1919-1925, 86.

39. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastro-paresis syndrome. Eur J Clin Invest 1984;14:420.

40. Darwiche G, Bjorgell O, Thorsson O, Almer LO. Correlation between simultaneous scinti-graphic and ultrasonographic measurement of gastric emptying in patients with type 1 diabetes mellitus. J Ultrasound Med 2003;22(5):459-466.

41. Lawlor PM, McCullough JA, Byrne PJ, Reynolds JV. Electrogastrography: a non-invasive measurement of gastric function. Ir J Med Sci 2001;170(2):126-131.

42. Malagelada JR, Stanghellini V. Manometric evaluation of upper gut symptoms. Gastroenterology 1985;88:1223.

43. Malagelada JR, Camilleri M, Stanghellini V. Manometric diagnosis of gastrointestinal motility disorders. Thieme-Stratton, New York, 1986.

44. O'Donovan D, Feinle-Bisset C, Jones K, Horowitz M. Idiopathic and Diabetic Gastroparesis. Curr Treat Options Gastroenterol 2003;6(4):299-309.

45. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61(2):160-173; quiz 175-176.

46. Okamoto H, Nomura M, Nakaya Y, et al. Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis. Int Med 2003;42(8):655-664.

47. Stanciu GO. Gastroparesis and its management. Rev Med Chir Soc Med Nat Iasi 2001; 105(3):451-456.

48. Gentilcore D, O'Donovan D, Jones KL, Horowitz M. Nutrition therapy for diabetic gastroparesis. Curr Diab Rep 2003;3(5):418-426.

49. Keil R. Prokinetics and diabetes mellitus. Vnitr Lek 2004;50(5):358,360-362.

50. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol 2003;98(2):264-271.

51. Lata PF, Pigarelli DL. Chronic metoclopramide therapy for diabetic gastroparesis. Ann Pharmacother 2003;37(1):122-126.

52. Franzese A, Borrelli O, Corrado G, et al. Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther 2002;16(5):951-957.

53. Russo A, Stevens JE, Giles N, et al. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. Aliment Pharmacol Ther 2004;20(3):333-338.

54. Talley NJ, Verlinden M, Geenen DJ, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 2001;49(3):395-401.

55. Huilgol V, Evans J, Hellman RS, Soergel KH. Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls. Aliment Pharmacol Ther 2002;16(5):945-950.

56. Dishy V, Cohen Pour M, Feldman L, et al. The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis. Clin Pharmacol Ther 2004;76(3):281-286.

Lacy BE, Crowell MD, Schettler-Duncan A, Mathis C, Pasricha PJ. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004;27(10):2341-2347.

Lacy BE, Zayat EN, Crowell MD, Schuster MM. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002;97(6):1548-1552. Ezzeddine D, Jit R, Katz N, Gopalswamy N, Bhutani MS. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002;55(7):920-923. Forster J, Sarosiek I, Delcore R, Lin Z, Raju GS, McCallum RW. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 2001;182(6):676-681. Abell T, Lou J, Tabbaa M, Batista O, Malinowski S, Al-Juburi A. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. JPEN J Parenter Enteral Nutr 2003;27(4):277-281. Forster J, Sarosiek I, Lin Z, et al. Further experience with gastric stimulation to treat drug refractory gastroparesis. Am J Surg 2003;186(6):690-695.

Lin Z, Forster J, Sarosiek I, McCallum RW. Treatment of diabetic gastroparesis by high-

frequency gastric electrical stimulation. Diabetes Care 2004;27(5):1071-1076.

Watkins PJ, Buxton-Thomas MS, Howard ER. Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabete Med 2003;20(1):58-63.

Anjaneyulu M, Ramarao P. Studies on gastrointestinal tract functional changes in diabetic animals. Methods Find Exp Clin Pharmacol 2002;24(2):71-75.

El-Salhy M, Spangeus A. Gastric emptying in animal models of human diabetes: correlation to blood glucose level and gut neuroendocrine peptide content. Ups J Med Sci 2002;107(2):89-99.

Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care 2004;27(12):2942-2947. Rosa-e-Silva L, Troncon LE, Oliveira RB, Foss MC, Braga FJ, Gallo Junior L. Rapid distal small bowel transit associated with sympathetic denervation in type I diabetes mellitus. Gut 1996;39(5):748-756.

Camilleri M, Stanghellini V, Sheps SG, Malagelada JR. Gastrointestinal motility disturbances due to postganglionic sympathetic lesions (abstract). Clin Res 1984;32:489A. Nunes AC, Pontes JM, Rosa A, Gomes L, Carvalheiro M, Freitas D. Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus. Am J Gastroenterol 2003;98(12):2672-2675.

Richter ML, Wagner T. Pancreatic exocrine insufficiency in patients with diabetes melli-tus. Current state of our knowledge and practical consequences. Fortschr Med Orig 2001;119(Suppl 2):77-79.

Hoffmann IS, Roa M, Torrico F, Cubeddu LX. Ondansetron and metformin-induced gastrointestinal side effects. Am J Ther 2003;10(6):447-451.

Bargen JA, Bollman JL, Kepler EJ. The "diarrhea of diabetes" and steatorrhea of pancreatic insufficiency. Proc Staff Meet Mayo Clin 1936;11:737.

Bo-Linn G, Fordtran JS. Fecal fat concentration in patients with steatorrhea. Gastroenterology 1984;87:319.

Ogbonnaya K, Arem R. Diabetic diarrhea. Arch Intern Med 1990;150:262-267. Farthing M. Effective treatment of diabetic diarrhea with a somatostatin analogue. Gut 1992;33:1578-1580.

Nakabayashi H, Fujii S, Milwa U, Seta T, Takeda R. Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide. Arch Int Med 1994;154:1863-1867. Meyer C, O'Neal DN, Connell W, Alford F, Ward G, Jenkins AJ. Octeotride treatment of severe diabetic diarrhoea. Int Med J 2003;33:617-624.

Spangeus A, El-Salhy M, Suhr O, Eriksson J, Lithner F. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand J Gastroenterol 1999; 34(12):1196-1202.

80. Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000;160(18):2808-28l6.

81. Maleki D, Camilleri M, Burton DD, et al. Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci 1998;43(11):2373-2378.

82. Jung HK, Kim DY, Moon IH, Hong YS. Colonic transit time in diabetic patients— comparison with healthy subjects and the effect of autonomic neuropathy. Yonsei Med J 2003;44(2):265-272.

83. Ron Y, Leibovitz A, Monastirski N, Habot B, Segal R. Colonic transit time in diabetic and nondiabetic long-term care patients. Gerontology 2002;48(4):250-253.

84. Iida M, Ikeda M, Kishimoto M, et al. Evaluation of gut motility in type II diabetes by the radiopaque marker method. J Gastroenterol Hepatol 2000;15(4):381-385.

85. Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ. Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults. Am J Gastroenterol 2003;98(2):391-398.

86. Russo A, Sun WM, Sattawatthamrong Y, et al. Acute hyperglycaemia affects anorectal motor and sensory function in normal subjects. Gut 1997;41(4):494-499.

87. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2002;97(12):3087-3094.

88. Martelli H, Devroede G, Arhan P, Duguay C, Dornic C, Faverdin C. Some parameters of large bowel motility in normal man. Gastroenterology 1978;75:612.

89. Ron Y, Wainstein J, Leibovitz A, et al. The effect of acarbose on the colonic transit time of elderly long-term care patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 2002;57(2):M111-M114.

90. Epanomeritakis E, Koutsoumbi P, Tsiaoussis I, et al. Impairment of anorectal function in diabetes mellitus parallels duration of disease. Dis Colon Rectum 1999;42(11):1394-1400.

91. Fusgen I, Gruss HJ. Fecal incontinence in elderly diabeteic patients. Wien Med Wochenschr 2003;153(17-18):398-401.

92. Sun WM, Katsinelos P, Horowitz M, Read NW. Disturbances in anorectal function in patients with diabetes mellitus and faecal incontinence. Eur J Gastroenterol Hepatol 1996;8(10):1007-1012.

93. Stevens TK, Softer EE, Palmer RM. Fecal incontinence in elderly patients: common, treatable, yet often undiagnosed. Cleve Clin J Med 2003;70(5):441-448.

94. Wald A. Incontinence and anorectal dysfunction in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995;7(8):737-739.

95. Cooper ZR, Rose S. Fecal incontinence: a clinical approach. Mt Sinai J Med 2000; 67(2):96-105.

Anti-Aging Report

Anti-Aging Report

When people generally think about anti-aging, they tend to think about the visible signs of wear and tear, those tell-tale wrinkles, age spots and their developing jowls. No-one wants to get old, let alone feel and look older than their years and anti-aging treatments are becoming so sought after by both men and women that the skincare market is colossal, but what really works?

Get My Free Ebook

Post a comment